Pherecydes Pharma SA announced that it has received €8.7 million in its series B round of funding led by new investor Go Capital SAS on January 16, 2018. The transaction also involved participation from new investors Omnes Capital S.A.S., Fa Dièse, business angels from the Rhône-Alpes region, existing investors Auriga Partners, ACE Management, and Participations Besançon. The company has raised €13.6 million in funding till date. Representatives from Go Capital SAS and Omnes Capital S.A.S. will be appointed to the company's supervisory board.